Correlation Between Cue Biopharma and Zenith Capital
Can any of the company-specific risk be diversified away by investing in both Cue Biopharma and Zenith Capital at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cue Biopharma and Zenith Capital into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cue Biopharma and Zenith Capital Corp, you can compare the effects of market volatilities on Cue Biopharma and Zenith Capital and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cue Biopharma with a short position of Zenith Capital. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cue Biopharma and Zenith Capital.
Diversification Opportunities for Cue Biopharma and Zenith Capital
-0.07 | Correlation Coefficient |
Good diversification
The 3 months correlation between Cue and Zenith is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding Cue Biopharma and Zenith Capital Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zenith Capital Corp and Cue Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cue Biopharma are associated (or correlated) with Zenith Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zenith Capital Corp has no effect on the direction of Cue Biopharma i.e., Cue Biopharma and Zenith Capital go up and down completely randomly.
Pair Corralation between Cue Biopharma and Zenith Capital
Considering the 90-day investment horizon Cue Biopharma is expected to generate 351.68 times less return on investment than Zenith Capital. But when comparing it to its historical volatility, Cue Biopharma is 18.99 times less risky than Zenith Capital. It trades about 0.01 of its potential returns per unit of risk. Zenith Capital Corp is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest 13.00 in Zenith Capital Corp on August 29, 2024 and sell it today you would lose (2.00) from holding Zenith Capital Corp or give up 15.38% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cue Biopharma vs. Zenith Capital Corp
Performance |
| Timeline |
| Cue Biopharma |
| Zenith Capital Corp |
Cue Biopharma and Zenith Capital Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cue Biopharma and Zenith Capital
The main advantage of trading using opposite Cue Biopharma and Zenith Capital positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cue Biopharma position performs unexpectedly, Zenith Capital can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zenith Capital will offset losses from the drop in Zenith Capital's long position.| Cue Biopharma vs. Coya Therapeutics, Common | Cue Biopharma vs. Lantern Pharma | Cue Biopharma vs. Fennec Pharmaceuticals | Cue Biopharma vs. Eliem Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |